India Medtronic Ltd, a subsidiary of Minneapolis, MN-headquartered Medtronic, launched GI Genius, an artificial intelligence-driven endoscopy module for the treatment of colorectal cancer in India.
The GI Genius module uses advanced AI software to highlight suspicious polyps of various sizes, shapes, and morphologies with a visual marker in real-time, the company said in a statement. “It serves as the gastroenterologists’ ever-vigilant second observer, with a sensitivity rate per lesion of 99.7% and less than 1% false positive,” it added.
Per Globocan 2020, an online database providing global cancer statistics and estimates of incidence and mortality in 185 countries for 36 types of cancer, colorectal cancer is the seventh deadliest cancer in India among both men and women.
There is an increased incidence trend in India due to changing lifestyles that include consumption of calorie rich, processed food, low fiber diet and lack of physical activity. Doctors say that symptoms of colorectal cancer are difficult to identify and timely screening and diagnosis are important.
AIG Hospital in Hyderabad India, was the first to utilize the enhanced screening feature with GI Genius. Dr. D. Nageshwar Reddy, chairman and chief of gastroenterology at the hospital said, ” Technologically innovative and effective interventions such as these will play a significant role in enhancing our ability to combat the challenges arising from delayed diagnosis of colorectal cancer.”
